<div id="readability-page-1"><div>** Shares of Sino Biopharmaceutical rise 5.6% to HK$6.97, on track for biggest one-day pct gain since November 13 ** Stock hits the highest point since January 29 on the sixth straight session of rise** Co says its breast cancer drug TQB2102 &#34;HER2 bispecific ADC&#34; is undergoing phase III clinical trial to evaluate efficacy and safety of the product for injection versus investigator-selected chemotherapy in HER2-Low breast cancer** Says enrolment of all subjects has recently been completed ** YTD, stock up 12%, the Hang Seng Biotech Index (.HSBIO) up 13.4%</div></div>

Sino Biopharmaceutical shares rose 5.6% to HK$6.97, marking the largest one-day gain since November 13. The stock reached its highest point since January 29, continuing a six-day upward trend. The company announced that its breast cancer drug TQB2102, a HER2 bispecific ADC, is in phase III clinical trials, with subject enrollment recently completed. Year-to-date, the stock is up 12%, while the Hang Seng Biotech Index has increased by 13.4%.

Reuters

Guotai CSI Bio-medicine ETF

E Fund CSI 300 Health Care ETF

E Fund CSI Biotechnology Theme ETF

SINO BIOPHARM

Founder Fubon CSI Medicine and Medical Device Innovation ETF

ChinaAMC SSE STAR Biology and Medicine ETF

Hwabao WP Hang Seng SCHK Innovative Drug Select ETF

ChinaAMC CSI Biotechnology Theme ETF

China Universal 800 Health Care ETF

GF CSI HK Innovative Drugs Industry ETF(QDII)

Penghua CSI HK Connect Health Care Composite ETF

Tianhong CNI BIOMEDICINE ETF

ChinaAMC Hang Seng Biotechnology Technology ETF(QDII)

Fullgoal Hang Seng SCHK Innovative Drug & Healthcare ETF

Huaan Hang Seng Biotech ETF

Guotai Hang Seng Biotech ETF

ChinaAMC SSE Health Care ETF Initiating Fund

China Southern Hang Seng Biotech ETF(QDII)

Guotai SSE STAR Brand Name Drug ETF

Yinhua CSI Innovative Drugs Industry ETF

E Fund Hang Seng SCHK Innovative Drug ETF

Ping An CSI Medicine and Medical Device Innovation ETF

Penghua SSE STAR Biology and Medicine ETF

China Universal CSI Biotechnology Theme Index Initiating Fund(LOF)-A

ICBCCS SSE STAR Biology and Medicine ETF

Minsheng Royal CSI Biotechnology Theme ETF

China Merchants CSI Biotechnology Theme ETF

Sino Biopharmaceutical rises on progress of breast cancer drug